Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The Clinical Impact of Time-restricted Eating on Cancer: A Systematic Review

Title: The Clinical Impact of Time-restricted Eating on Cancer: A Systematic Review
Authors: Stringer, Eleah J; Cloke, Rob W G; Van der Meer, Lindsay; Murphy, Rachel A; Macpherson, Nicol A; Lum, Julian J
Contributors: Michael Smith Health Research BC; Lotte & John Hecht Memorial Foundation; BC Cancer Foundation; Canadian Institutes of Health Research; Terry Fox Research Institute New Frontiers Program; Lotte and John Hecht Memorial Foundation
Source: Nutrition Reviews ; volume 83, issue 7, page e1660-e1676 ; ISSN 0029-6643 1753-4887
Publisher Information: Oxford University Press (OUP)
Publication Year: 2024
Description: Context In the face of the growing global burden of cancer, there is increasing interest in dietary interventions to mitigate its impacts. Pre-clinical evidence suggests that time-restricted eating (TRE), a type of intermittent fasting, induces metabolic effects and alterations in the gut microbiome that may impede carcinogenesis. Research on TRE in cancer has progressed to human studies, but the evidence has yet to be synthesized. Objective The objective of this study was to systematically evaluate the clinical and/or metabolomic effects of TRE compared with ad libitum eating or alternative diets in people with cancer. Data Sources Ovid MEDLINE, Ovid Embase, CINAHL, Ovid Cochrane Central Register of Control Trials (CENTRAL), Web of Science Core Collection (ESCI, CPCI-SSH, CPCI-S), and SCOPUS were searched up to January 4, 2023, using the core concepts of “intermittent fasting” and “cancer.” Original study designs, protocols, and clinical trial registries were included. Data Extraction After evaluating 13 900 results, 24 entries were included, consisting of 8 full articles, 2 abstracts, 1 published protocol and 13 trial registries. All data were extracted, compared, and critically analyzed. Data Analysis There was heterogeneity in the patient population (eg, in tumor sites), TRE regimens (eg, degree of restriction, duration), and clinical end points. A high rate (67–98%) of TRE adherence was observed, alongside improvements in quality of life. Four articles assessed cancer markers and found a reduction in tumor marker carcinoembryonic antigen, reduced rates of recurrence, and a sustained major molecular response, following TRE. Five articles demonstrated modified cancer risk factors, including beneficial effects on body mass index, adiposity, glucoregulation, and inflammation in as short a period as 8 weeks. None of the completed studies assessed the effect of TRE on the microbiome, but analysis of the microbiome is a planned outcome in 2 clinical trials. Conclusions Preliminary findings suggest that ...
Document Type: article in journal/newspaper
Language: English
DOI: 10.1093/nutrit/nuae105
Availability: https://doi.org/10.1093/nutrit/nuae105; https://academic.oup.com/nutritionreviews/article-pdf/83/7/e1660/58972187/nuae105.pdf
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.1E5785F
Database: BASE